The University of Kansas Cancer Center (KUCC) (Kansas City Cancer Center (KCCC)) - North is a clinical research site located in Kansas City, Missouri, United States 64154.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
The University of Kansas Cancer Center (KUCC) (Kansas City Cancer Center (KCCC)) - North has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma.
Sponsors: Ono Pharmaceutical Co. Ltd.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
The University of Kansas Cancer Center (KUCC) (Kansas City Cancer Center (KCCC)) - North has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
The University of Kansas Cancer Center (KUCC) (Kansas City Cancer Center (KCCC)) - North has 1 clinical trials on record, with 1 currently active. Their work covers Refractory Primary Central Nervous System Lymphoma, Primary CNS Lymphoma.
The University of Kansas Cancer Center (KUCC) (Kansas City Cancer Center (KCCC)) - North has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.